The Food and Drug Administration still isn’t cutting cannabidiol, or CBD, much slack. This week, the agency updated their stance on the cannabis-derived ingredient, warning the public that most products made with CBD on the market are untested, unregulated, and have the “potential to harm” users. It also issued more than a dozen warning letters to companies they claim are illegally selling CBD products.